Table 4. Cardiovascular risk factors among the study population as a whole and by blood pressure control status.
Whole group | Controlled HT | Uncontrolled HT | |||
Variable | n | (n = 298) | (n = 67) | (n = 231) | p-value |
Age, % | 298 | 86 | 87 | 86 | 0.989 |
Smoking, % | 298 | 3 | 2 | 3 | 0.348 |
Alcohol, % | 298 | 17 | 18 | 17 | 0.462 |
Overweight, % | 298 | 35 | 31 | 36 | 0.228 |
Obesity, % | 298 | 17 | 16 | 22 | 0.228 |
Central obesity, % | 298 | 66 | 66 | 66 | 1.000 |
Diabetes, % | 298 | 37 | 22 | 42 | 0.003 |
Hypercholesterolaemia, % | 259 | 17 | 61 | 51 | 0.229 |
Low HDL-C, % | 259 | 16 | 13 | 24 | 0.034 |
Hypertriglyceridaemia, % | 259 | 18 | 18 | 15 | 0.700 |
Hyperuricaemia, % | 259 | 33 | 33 | 36 | 0.210 |
Dipstick proteinuria, % | 227 | 16 | 18 | 12 | 0.396 |
Renal failure, % | 255 | 30 | 12 | 21 | 0.103 |
ECG-LVH, % | 164 | 21 | 16 | 14 | 0.843 |
MetS, % | 298 | 10 | 8 | 15 | 0.105 |
Global CV risk, % | 298 | ||||
Low | 31 | 69 | 19 | 0.0001 | |
Moderate | 39 | 18 | 45 | 0.0006 | |
High/very high | 30 | 13 | 38 | 0.03 |
Data are expressed as mean ± standard deviation (SD) or relative frequency (%).
HDL-C, high-density lipoprotein cholesterol; ECG-LVH, electrocardiographically determined left ventricular hypertrophy; MetS, metabolic syndrome; CV, cardiovascular risk.